Cover Image
市場調查報告書

視網膜症:全球臨床實驗檢討

Retinopathy Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 322181
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
視網膜症:全球臨床實驗檢討 Retinopathy Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 110 Pages
簡介

本報告提供視網膜症的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 視網膜症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病臨床實驗上視網膜症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病臨床實驗上視網膜症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

視網膜症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • SIFI S.p.A
    • Shire Plc
    • Mednax, Inc.
    • Insmed Incorporated
    • Gene Signal International SA
    • EyeGene, Inc.
    • AstraZeneca PLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Eye Institute
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • 名古屋大學
    • Manhattan Eye Ear & Throat Hospital
    • Azienda Ospedaliero-Universitaria Meyer
    • Dr. Sami Ulus Children's Hospital
    • Weill Cornell Medical College
    • Islamic Azad University of Tabriz
    • The Children's Hospital of Philadelphia
    • Kansai Medical University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3818CTIDB

GlobalData's clinical trial report, "Retinopathy Global Clinical Trials Review, H2, 2016" provides an overview of Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Retinopathy Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 107

  • Abbreviations 107
  • Definitions 107
  • Research Methodology 108
  • Secondary Research 108
  • About GlobalData 109
  • Contact Us 109
  • Disclaimer 109
  • Source 110

List of Tables

  • Retinopathy Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Retinopathy Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Retinopathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Retinopathy Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

  • Retinopathy Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Retinopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Retinopathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Retinopathy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 108
Back to Top